LiveWell mBC パイロット RCT
LiveWell mBC: 転移性乳がんを抱える女性のグループにおける適応型弁証法的行動療法スキルトレーニングプログラムのパイロットテスト
In this pilot randomized controlled trial, women with metastatic breast cancer and at least mild distress (N=48) will be randomized to receive LiveWell mBC, a group-based adapted Dialectical Behavioral Therapy (DBT) Skills Training protocol, or Usual Care. The investigators will evaluate feasibility, acceptability, and preliminary efficacy of LiveWell to reduce distress (primary outcome) and improve psychological well-being, symptom burden, and quality of life (secondary outcomes).
調査の概要
状態
条件
詳細な説明
Participants will be randomized 2:1 to receive LiveWell mBC, an adapted DBT Skills Training intervention delivered to small groups of women with mBC via telehealth, or usual care. LiveWell mBC involves orientation + an 8-session skills training protocol of mindfulness, emotion regulation, distress tolerance and interpersonal effectiveness.
Participants will complete self-report measures at baseline, mid-intervention (Week 5), post-intervention (Week 11) and 1 month post-intervention (Week 15). It is hypothesized that: 1) RCT methods will demonstrate evidence of feasibility (>70% overall retention rate, >70% LiveWell mBC completion rate); 2) RCT methods will demonstrated evidence of acceptability (>50% enrollment rate, >80% participant satisfaction); and 3) LiveWell participants will demonstrate reductions in distress (primary outcome) compared to Usual Care at 11-week follow-up.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Kathryn Moody
- 電話番号:843-792-9698
- メール:moodykat@musc.edu
研究連絡先のバックアップ
- 名前:Benjamin Axelrod
- 電話番号:843-876-2645
- メール:axelrod@musc.edu
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- identify as female
- be diagnosed with metastatic (AJCC stage IV) breast cancer
- be receiving care for metastatic breast cancer at Hollings Cancer Center
- endorse >3 out of 10 on the NCCN distress thermometer over the past week plus at least one emotional concern on the problem checklist
- be > 18 years of age
- be able to understand, speak, and read English
- be able to provide informed consent.
Exclusion Criteria:
- reported or suspected cognitive impairment
- presence of untreated serious mental illness (e.g., schizophrenia) indicated by the medical chart or treating oncologist
- expected survival <6 months, as indicated by a hospice referral
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし:Usual Care
Will receive a handout with general support resources available at Hollings Cancer Center. |
|
|
実験的:LiveWell mBC: A Group-Based Adapted Dialectical Behavioral Therapy Skills Training Program
Will receive 9 telehealth-delivered small group (6-8 participants) sessions (orientation + 8 session DBT skills training protocol) co-facilitated by two skills trainers. Sessions will be 90 minutes each and delivered approximately weekly. Sessions will teach skills from dialectical behavioral therapy (e.g., mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness) adapted for patients with metastatic breast cancer. Sessions follow a standardized structure, including 1) mindfulness practice, 2) home practice and diary card review, 3) learning and practicing new skills, and 4) closing ritual. Participants will have access to a resource library of skills training videos and mindfulness recordings. |
LiveWell mBC: A Group-Based Adapted Dialectical Behavioral Therapy Skills Training Program |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
PROMIS Depression Short Form (8a)
時間枠:Baseline (week 0), post-intervention (week 11), and 1-month follow-up (week 15)
|
Depression will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (8 items) Short Form Scale. PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater depressive symptomology. |
Baseline (week 0), post-intervention (week 11), and 1-month follow-up (week 15)
|
|
PROMIS Anxiety Short Form (7a)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
Anxiety will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety (7 items) Short Form Scale. PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater anxiety symptomology. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Intolerance of Uncertainty Scale - Short Form (IUS-12)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The 12-item Intolerance of Uncertainty Scale (IUS) Short Form will be used to measure emotional, cognitive, and behavioral reactions to uncertain situations. The IUS has a score range of 12-60, where a higher score indicates greater intolerance of uncertainty. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
Peace, Equanimity, and Acceptance in the Cancer (PEACE) - Peaceful Acceptance of Illness Subscale
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The 5-item Peace, Equanimity, and Acceptance in the Cancer (PEACE) - Peaceful Acceptance of Illness Subscale will be used to assess patient-reported acceptance, inner peace, and tranquility in the context of cancer. The subscale has a score range of 5-20, where a higher score indicates greater peaceful acceptance of illness. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
PROMIS Positive Affect Short Form (15a)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The PROMIS Positive Affect Short Form 15a will be used to assess patient-reported positive emotions and well-being over the past 7 days. PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater positive affect. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
Difficulty in Regulating Emotions Scale (DERS-18)
時間枠:Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
The DERS-18 will be used to assess emotion dysregulation. The DERS-18 has a score range of 18-80, where a higher score indicates greater difficulty with regulating emotions. |
Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
時間枠:Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
The 10-item Cognitive and Affective Mindfulness Scale-Revised will be used to assess patient-reported mindfulness qualities, including present-moment awareness, acceptance, and attention. The CAMS-R has a score range of 10-40, where a higher score indicates greater mindfulness. |
Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
DBT Ways of Coping Checklist (DBT-WCCL) - DBT Skills Subscale (DSS)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The DBT Ways of Coping Checklist (DBT-WCCL) -DBT Skills Subscale (DSS) will be used to assess patient-reported frequency of skill use to manage difficult situations. The DBT-WCCL has a score range of 0 to 4, where a higher score indicates greater DBT skill use. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
NCI Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (NCI-PRO-CTCAE)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The NCI-PRO-CTCAE will be used to assess patient-reported symptom frequency, severity, and interference related to breast cancer and its treatment. Items are rated on a 5-point Likert scale, with higher scores indicating greater symptom burden. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
PROMIS Self-Efficacy for Managing Emotions Short Form (8a)
時間枠:Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
The PROMIS Self-Efficacy for Managing Emotions 8-item Short Form will be used to assess patient-reported confidence in managing negative emotions and emotional distress related to chronic illness. PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater self-efficacy for managing emotions. |
Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
PROMIS Self-Efficacy for Managing Symptoms Short Form (8a)
時間枠:Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
The PROMIS Self-Efficacy for Managing Symptoms 8-item Short Form will be used to assess patient-reported confidence in managing symptoms and limiting their interference with daily life. PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater self-efficacy for managing symptoms. |
Baseline (week 0), mid-point of intervention (week 5), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
Functional Assessment of Cancer Therapy - Breast (FACT-B)
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The FACT-B will be used to assess patient-reported quality of life across physical, social/family, emotional, and functional domains, as well as breast cancer-specific concerns. Items are rated on a 5-point Likert scale (0 = Not at all to 4 = Very much) and summed to form subscale and total scores. Higher subscale and total scores indicate better quality of life. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
PROMIS Emotional Support
時間枠:Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
The PROMIS Emotional Support (4a) Short Form will assess social support. The PROMIS scores are expressed as T-scores, with a mean of 50 and a standard deviation of 10. Higher scores indicate greater access to social support networks. |
Baseline (week 0), post-intervention (week 11), and 1 month follow-up (week 15)
|
|
Group Therapy Experience Scale
時間枠:Post-intervention (week 11)
|
The Group Therapy Experience Scale will measure perceived cohesion, self-disclosure, and satisfaction with group therapy. The 16 item scale uses a Likert scale with responses ranging from 1(strongly disagree) to 5(strongly agree). Higher scores indicate higher satisfaction with group therapy. |
Post-intervention (week 11)
|
協力者と研究者
捜査官
- 主任研究者:Kelly Hyland, PhD、Medical University of South Carolina
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。